Fentanyl

An analysis of recent drug use in the United States revealed unexpected trends in substances being used in tandem with fentanyl, according to an expert.

Low-dose initiation of buprenorphine in an outpatient setting showed low rates of success among a cohort of adults with opioid use disorder who self-reported daily fentanyl use, according to a study published in JAMA Network Open.

New data show that rapid initiation with once-monthly Sublocade significantly improved treatment retention vs. standard initiation among patients with opioid use disorder, according to a press release.

Fentanyl-involved overdose mortality rates were disproportionately high among American Indian or Alaska Native and Black individuals compared with other racial and ethnic groups, according to a research letter published in JAMA Psychiatry.

Higher doses of buprenorphine were associated with significantly lower rates of acute care utilization among adults with opioid use disorder compared with the FDA’s recommended dose, according to a study published in JAMA Network Open.

The CDC issued a warning to health care officials, clinicians and patients about a potential risk for overdose among people ordering counterfeit prescription medications from online pharmacies.

Three people have died and 40 others have been hospitalized across 13 states due to a Listeria outbreak related to sliced deli meats, according to the CDC.

A new study provides the first evidence that illicit fentanyl use may play a role in hepatitis C transmission among injection drug users, according to researchers.

The number of pills containing illicit fentanyl that were seized by United States law enforcement in 2023 was 2,300 times greater than the number in 2017, according to a study published in the International Journal of Drug Policy.

Patients with opioid use disorder, or OUD, who were treated with buprenorphine during an ED visit had greater odds of continued treatment engagement 30 days later, a study in JAMA Network Open showed.